Table 5. Proportion of drug resistance in re-treated tuberculosis cases tested in 11 Chinese provinces.

Province	Number of patients tested	Any resistance	Resistance to rifampin	Multidrug resistance (MDR) ‡
North region in China
Jilin	597	53.0%	28.9%	23.2%
Heilongjiang	421	67.5%	40.4%	30.4%
Liaoning	86	55.8%	29.1%	24.5%
Inner Mongolia	308	70.1%	51.0%	41.9%
Beijing	154	35.1%	14.9%	11.7%
Henan	726	66.0%	43.5%	34.4%
Shandong	220	50.0%	25.1%	23.2%
South region in China
Shanghai	200	27.5%	15.0%	12.5%
Zhejiang	145	59.3%	44.1%	34.5%
Guangdong	166	33.7%	19.9%	15.6%
Hubei	238	44.5%	26.9%	21.9%
China	892	54.5%	29.4%	25.6%